Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    10228190 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's Disease
Condition: Crohn Disease
Interventions: Drug: Infliximab 10 mg/kg;   Drug: Infliximab 5 mg/kg;   Drug: Placebo
2 Completed Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas
Conditions: Inflammatory Bowel Disease;   Intestinal Fistula
Intervention: Drug: AST-120
3 Active, not recruiting Treatment of Fistulous Crohn's Disease by Implant of Autologous Mesenchymal Stem Cells Derived From Adipose Tissue
Condition: Crohn Disease
Intervention: Other: Autologous mesenchymal stem cells

Indicates status has not been verified in more than two years